Is the E-cadherin downregulation observed in Helicobacter pylori infection associated with gastric cancer development? An additional element in the disease jigsaw

Experimental Oncology

Volumn 25, Issue 4, 2003, Pages 270-273

  Charalabopoulos, K ^a,b   Papalimneou, V ^a,b,c   Evangelou, A ^a   Kalfakakou, V ^a   Kiortsis, D ^a   Kolettas, E ^a   Alamanos, J ^a   Charalabopoulos, A ^a   Agnantis, N J ^a  

^a UNIVERSITY OF IOANNINA   (Greece)

^b RED CROSS HOSPITAL   (Greece)

^c Larissa State Hospital   (Greece)

Author keywords

Adhesion molecules; E cadherin; Gastric cancer; Gastritis; Helicobacter pylori; MALT lymphoma; Peptic ulcer disease

Indexed keywords

CELL ADHESION MOLECULE; UVOMORULIN;

ADULT; AGED; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL INFECTION; DOWN REGULATION; DUODENUM ULCER; FEMALE; GASTRITIS; GASTROINTESTINAL ENDOSCOPY; HELICOBACTER; HELICOBACTER PYLORI; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; MUCOSA ASSOCIATED LYMPHOID TISSUE LYMPHOMA; STOMACH BIOPSY; STOMACH CANCER; STOMACH CARCINOGENESIS; STOMACH MUCOSA; STOMACH ULCER; CANCER GROWTH; CONTROLLED STUDY; DUODENOSCOPY; GASTROINTESTINAL SYMPTOM; PROTEIN EXPRESSION;

EID: 0742323490     PISSN: 02043564     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (45)

1. Peterson WL. Helicobacter pylori and peptic ulcer disease. N Engl J Med 1991; 324: 1043-8.
2. Cover TL, Blaser MJ. Helicobacter pylori and gastroduodenal disease. Ann Rev Med 1992; 43: 135-45.
3. NIH Consensus Conference. Helicobacter pylori in peptic ulcer disease. NPH Consensus Development Panel on Helicobacter pylori in peptic ulcer disease. JAMA 1994; 272: 65-9.
4. Moller H, Heseltine E, Vaino H. Working group report on schistosomes, liver flukes, and Helicobacter pylori. Int J Cancer 1995; 60: 587-9.
5. Isaacson PG. Lymphomas of mucosa-associated lymphoma tissue (MALT). Histopathology 1990; 16: 617-9.
6. Parsonnet J, Hansen S, Rodriquez L, Gelb AB, Warnke RA, Jellum B, Orentreich N, Vogelman JH, Friedman GD. Helicobacter pylori infection and gastric lymphoma. N Engl J Med 1994; 330: 1267-71.
7. Whincup PH, Mendall MA, Perry IJ, Strachamm DP, Walker M. Prospective relations between Helicobacter pylori infection, coronary heart disease, and stroke in middle aged men. Heart 1996; 75: 568-72.
8. Ernst PB, Pequet S. Interactions between Helicobacter pylori and the local mucosal immune system. Scand J Gastroenterol 1991; 26: 56-64.
9. Hatz RA, Brooks WP, Kramling HJ, Enders G. Stomach immunology and Helicobacter pylori infection. Curr Opion Gastroenterol 1992; 8: 993-1001.
10. Dixon MF. Helicobacter pylori and peptic ulceration: histopathological aspects. J Gastroenterol Hepatol 1991; 6: 125-30.
11. Finlay BB, Falkow S. Common themes in microbial pathogenicity revisited. Microbial Mol Biol Rev 1997; 61: 136-69.
12. Crabtree JE, Watt JI, Trjdowiewicz LZ, Peichl P, Nicols PH, Ramsay N, Primrose JN, Lindley JD. Interleukin-8 expression in Helicobacter pylori infected, normal and neoplastic gastroduodenal mucosa. J Clin Pathol 1994; 47: 61-6.
13. Springer TA. Traffic signals for lymphocyte recirculation and lenkocyte emigration: the multistep paradigm. Cell 1994; 76: 301-14.
14. Takeichi M. Cadherin cell adhesion receptors as a morphogenetic regulator. Science 1991; 251: 1451-5.
15. Charalabopoulos K, Binolis J, Karkabounas S. Adhesion molecules in carcinogenesis. Exp Oncol 2002; 24: 249-57.
16. Charalabopoulos K, Pignatelli M. Adhesion molecules and cancer. Arch Health Med 2001; 18: 16-9.
17. Pignatelli M. E-cadherin: a biological marker of tumor differentiation. J Pathol 1993; 171: 81-2.
18. Charalabopoulos K, Papalimneou V, Charalabopoulos A. Adhesion molecules and lung cancer. Exp Oncol 2003; 25: 16-21.
19. Umbas R, Isaacs WB, Bringuier PP, Schaafsma HE, Karthaus HF, Oosterhof GO, Debruyne FM, Schalken JA. Decreased E-cadherin expression is associated with poor prognosis in patients with prostate cancer. Cancer Res 1994; 54: 3929-33.
20. Briguer PP, Ubbas R, Schaafsma HE, Karthaus HF, Debruyne FM, Schalken JA. Decreased E-cadherin immunoreactivity correlates with poor survival in patients with bladder tumors. Cancer Res 1993; 53: 3241-5.
21. Syrigos K, Harrington K, Charalabopoulos K, Karayannakis A, Waxman J, Pignatelli M. Altered expression of the cadherin/catenin complex in bladder cancer. Eur Urol 1998; 33: 86.
22. Pignatelli M, Ansari JQ, Gunter P, Liu D, Hiravio S, Takeichi M, Kloppel G, Lemoine NR. Loss of membranous E-cadherin expression in pancreatic cancer: correlation with lymph node metastasis, high grade and advaced stage. J Pathol 1994; 174: 243-8.
23. Matijssen V, Peters HM, Schalkwijk KL, Manni JJ, Ruiter DJ. E-cadherin expression in head and neck squamous cell carcinoma is associated with clinical outcome. Int J Cancer 1993; 55: 580-5.
24. Vessey CJ, Wilding J, Folarin N, Hirano SMT, Soutter P, Stamp GWH, Pignatelli M. Altered expression and function of E-cadherin in cervical intraepithelial neoplasia and invasive squamous cell carcinoma. J Pathol 1995; 176: 151-9.
25. Jankowski J, Newham PM, Kandemiro O, Hirano S, Takeichi M, Pignatelli M. Differential expression of E-cadherin in normal, neoplastic and dysplastic oesophageal mucosa: a putative biomarker. Int J Oncol 1994; 4: 441-6.
26. Syrigos KN, Karayiannakis AJ, Charalabopoulos K, Katirzoglou N, Pignatelli M. Abnormal expression of E-cadherin in dysplastic Barrett's oesophagus. Ann Gastroenterol 2000; 13: 168.
27. Mayer B, Johnson JP, Leitl F, Jauch KW, Heiss MM, Schildberg FW, Birchmeier W, Funke I. E-cadherin expression in primary and metastatic gastric cancer down regulation correlates with cellular dedifferentiation and gradular disintegration. Cancer Res 1993; 53: 1690-5.
28. Gagliardi G, Kandemir O, Liu D, Guida M, Benvestito S, Ruers TGM, Benjamin IS, Northover JMA, Stamp GWH, Pignatelli M. Changes in E-cadherin immunoreactivity in the adenoma-carcinoma sequence of the large bowel. Virch Arch 1995; 426: 149-54.
29. Hessey SJ, Spencer J, Wyatt J, Solaba G, Rathbone BJ, Axon ATR, Dixon MF. Bacterial adhesion and disease activity in Helicobacter associated chronic gastritis. Gut 1990; 31: 134-8.
30. Sherman PM. Adherence and internalization of Helicobacter pylori by epithelial cells. In: H. pylori - basic mechanisms to clinical cure. Hunt RH, Tyrgat GNJ, eds. Boston: Kluwer Academic Press 1994; 148-62.
31. Garg PM, Territo MR, Karnes WE, Walsh JH. Helicobacter pylori secretes a chemotactic factor for monocytes and neutrophils. Gut 1992; 33: 1020-3.
32. Nai YEH, Rerez-Perez GI, Alley JB, Wahl SM, Blaser WJ, Smith PD. Surface proteins from Helicobacter pylori exhibit chemotactic activity for human leukocytes and are present in gastric mucosa. J Exp Med 1992; 175: 517-25.
33. Nielsen HS, Birkholz S, Andersen LP, Moran AP. Neutrophilic activation by Helicibacter pylori lipopolisaccharides. J Infect Dis 1994; 160: 135-9.
34. Marshall BJ, Warren JR. Unidentified curved baccili in the stomach of patients with gastritis and peptic ulceration. Lancet 1984; I: 1311-5.
35. Nomura A, Stemmerman GN, Chyon PH, Katol I, Perez-Perez GI, Bleser MJ. Helicobacter pylori infection and gastric carcinoma among japanese americans in Hawaii. N Engl J Med 1995; 325: 1132-6.
36. Parsonnet J, Friedman GD, Vandersteen DP, Chang Y, Vogelman JH, Orentreich N. Helicobacter pylori infection and the risk of gastric carcinoma. N Engl J Med 1992; 325: 1127-31.
37. Axon ATR, Lynch DAF. Helicobacter pylori, gastric physiology and cancer. Eur J Gastroenterol Hepatol 1993; 4: 1-7.
38. Sakaki N, Momma K, Yamada Y, Tajima T, Shoji F, Handa N, Takizawa T. Helicobacter pylori and early gastric cancer: relation to atrophic gastritis in background gastric mucosa. Eur J Gastroenterol Hepatol 1993; 5: 123-6.
39. Terres AM, Pajares JM, Hopkins AM, Murphy A, Moran AP, Baird AW, Kelleher D. HP disrupts epithelial barrier function in a process inhibited by protein kinase C activators. Infect Immun 1998; 66: 2943-50.
40. Cahill RL, Sant S, Beattie S, Hamilton H, O'Morain C. Helicobacter pylori and increased epithelial cell proliferation: a risk factor for cancer. Eur J Gastroenterol Hepatol 1994; 6: 1123-7.
41. Fan XG, Kelleher D, Fan XJ, Xia HX, Keeling PWN. Direct and indirect effects of Helicobacter pylori on cell cycle of gastric epithelial cell line AGS. Ir J Med Sci 1994; 163: 297-302.
42. Xiang Z, Censini S, Bayeli PE, Telford JL, Fijura N, Rappuoli R, Covacci A. Analysis of expression of Cag A and VacA virulence factors in 43 strains of HP reveals that clinical isolates can be divided into two major types and that CagA is not necessary for expression of the vacuolating cytotoxin. Infect Immun 1995; 63: 94-8.
43. Censini S, Lange C, Xiang Z, Crabtree JE, Ghiara P, Borodovsky M, Rappuoli R, Covacci A. CagA, a pathogenicity island of HP, encodes type I specific and disease associated virulence factors. Proc Natl Acad Sci USA 1996; 93: 14648-53.
44. Papini E, Satin B, Norais N, de Bernard M, Telford J, Rappuoli R. Selective increase of the permeability of the polarized epithelial cell monolayers by Helicobacter pylori vacuolating toxin. J Clin Invest 1998; 102: 813-20.
45. Rajasekaran AK, Hojo M, Huima J, Rodriguez-Boulan E. Catenins and zonula occludins-1 form a complex during stages in the assembly of tight junctions. J Cell Biol 1996; 132: 451-63.